What You Should Know:
- Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics raises $30M in Series B funding led by Koch Disruptive Technologies (KDT) and joined by existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures.
- Oshi Health is currently available to over 20 million people as a preferred in-network virtual gastroenterology clinic for
Read More
Oshi Health
HIMSS22 Day 2 Roundup: Google Partners with MEDITECH, Microsoft’s Health Cloud Strategy Expansions
Mergers & Acquisitions (M&A) Activity
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
OptimizeRx, a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. The acquisition includes the full Market Access Management Platform
Read More
Oshi Health Secures $23M to Expand Virtual Gastrointestinal Care
What You Should Know:
- Oshi Health, a virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced it has secured $23M in Series A funding. The round was co-led by Flare Capital Partners, Bessemer Venture Partners and Frist Cressey Ventures with a strategic investment from CVS Health Ventures. Takeda Digital Ventures, which has funded the company since its inception, also participated in the round along with several noteworthy health
Read More
Oshi Health Launches All-in-One Mobile App for IBD Management
Oshi Health, Inc. today announced the release of Oshi, a digital tracking mobile app with all-in-one features for inflammatory bowel disease (IBD) management and wellness including symptom tracking, curated learning, and expert Q&A. Oshi is now available for download on the Apple App Store or Android Google Play.Currently, there is no known cause or cure for Crohn's disease (CD) or ulcerative colitis (UC), the two main forms of IBD. Both are marked by inflammation in the lining of the
Read More
